Chris Comeaux and Robin Heffernan discuss the future of hospice care under Medicare Advantage, focusing on the roles of private equity and artificial intelligence.
Send us Fan Mail In Part One of this thought-provoking conversation, Chris Comeaux and Robin Heffernan explore the evolving intersection of private equity, artificial intelligence, and end-of-life care—raising critical questions about accountability, quality, and the future of hospice under Medicare Advantage. As the healthcare system shifts toward value-based models, the discussion challenges long-held assumptions about whether hospice should remain “carved out” or be fully integrated into p...